Standard Biotools (LAB) EBIT Margin Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -184.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,016.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | -3,846.00 |
| 10 | Standard Biotools | 311.34 Mn | -143.84 Mn | 11.31 Mn | 696.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 696.00 |
| Dec 31, 2025 | -2,544.00 |
| Sep 30, 2025 | -5,528.00 |
| Jun 30, 2025 | 8,729.00 |
| Mar 31, 2025 | -2,960.00 |
| Sep 30, 2024 | -5,208.00 |
| Jun 30, 2024 | -7,887.00 |
| Mar 31, 2024 | -7,324.00 |
| Dec 31, 2023 | 17,849.00 |
| Sep 30, 2023 | -6,976.00 |
| Jun 30, 2023 | -1,040.00 |
| Mar 31, 2023 | 41,594.00 |
| Dec 31, 2022 | -4,983.00 |
| Sep 30, 2022 | -6,104.00 |
| Jun 30, 2022 | -15,347.00 |
| Mar 31, 2022 | -5,659.00 |
| Sep 30, 2021 | -2,866.00 |
| Jun 30, 2021 | -729.00 |
| Mar 31, 2021 | -888.00 |
| Dec 31, 2020 | -641.00 |